Michael B. Hoffman
Michael B. Hoffman is an entrepreneur and businessperson who founded Northern Genesis Acquisition Corp., Northern Genesis Acquisition Corp. II, Northern Genesis Acquisition Corp. III and Stone Capital Partners LLC and who has been the head of 5 different companies. Presently, Michael B. Hoffman holds the position of Chairman for Annovis Bio, Inc., President & Chief Executive Officer of Northern Genesis Acquisition Corp. III and President of Northern Genesis Acquisition Corp. Mr. Hoffman is also Member-Executive Council at International Institute For Nanotechnology, Partner at Stone Capital Partners LLC and Managing Director at Northern Genesis Climate Solutions Corp. and on the board of 12 other companies.
In his past career Mr. Hoffman held the position of Chairman at Onconova Therapeutics, Inc., Partner at Riverstone Holdings LLC and Partner at Riverstone Investment Group LLC (a subsidiary of Riverstone Holdings LLC), Senior Managing Director at The Blackstone Group, Inc. (Illinois), President of Northern Genesis Acquisition Corp. II, Managing Director, Head-Mergers & Acquisitions at Smith Barney Harris Upham & Co., Inc. and Head-Mergers & Acquisitions at Smith Barney & Co., Inc.
Mr. Hoffman received a graduate degree and an undergraduate degree from Northwestern University and an MBA from Harvard Business School.
Transactions
| 01/04/2022 | 90 | Derivative/Non-derivative trans. at $19.78 per share. | 1,781 |
| 01/04/2022 | 7,142 | Derivative/Non-derivative trans. at $0.25 per share. | 1,785 |
| 01/04/2022 | 6,658 | Derivative/Non-derivative trans. at $19.78 per share. | 131,696 |
| 01/04/2022 | 30,000 | Derivative/Non-derivative trans. at $4.39 per share. | 131,700 |
| 01/31/2020 | 55,884 | Derivative/Non-derivative trans. at $4.8 per share. | 268,243 |
| 01/31/2020 | 1,137,942 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/31/2020 | 158,730 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 01/31/2020 | 33,333 | Acquisition at $6 per share. | 199,998 |
